Follow
Karina Martínez-Mayorga
Karina Martínez-Mayorga
Instituto de Química, UNAM
Verified email at iquimica.unam.mx
Title
Cited by
Cited by
Year
Recognizing pitfalls in virtual screening: a critical review
T Scior, A Bender, G Tresadern, JL Medina-Franco, K Martínez-Mayorga, ...
Journal of chemical information and modeling 52 (4), 867-881, 2012
4672012
How to recognize and workaround pitfalls in QSAR studies: a critical review
T Scior, JL Medina-Franco, QT Do, K Martínez-Mayorga, JA Yunes Rojas, ...
Current medicinal chemistry 16 (32), 4297-4313, 2009
2402009
Integrating virtual screening and combinatorial chemistry for accelerated drug discovery
F López-Vallejo, T Caulfield, K Martínez-Mayorga, M A Giulianotti, A Nefzi, ...
Combinatorial Chemistry & High Throughput Screening 14 (6), 475-487, 2011
1842011
Two protonation switches control rhodopsin activation in membranes
M Mahalingam, K Martínez-Mayorga, MF Brown, R Vogel
Proceedings of the National Academy of Sciences 105 (46), 17795-17800, 2008
1742008
Characterization of Activity Landscapes Using 2D and 3D Similarity Methods: Consensus Activity Cliffs
JL Medina-Franco, K Martínez-Mayorga, A Bender, RM Marín, ...
Journal of chemical information and modeling 49 (2), 477-491, 2009
1682009
Visualization of the chemical space in drug discovery
JL Medina-Franco, K Martínez-Mayorga, MA Giulianotti, RA Houghten, ...
Current Computer-Aided Drug Design 4 (4), 322-333, 2008
1682008
Mu-Opioid receptor biased ligands: A safer and painless discovery of analgesics?
A Madariaga-Mazón, AF Marmolejo-Valencia, Y Li, L Toll, RA Houghten, ...
Drug discovery today 22 (11), 1719-1729, 2017
1152017
Retinal counterion switch mechanism in vision evaluated by molecular simulations
K Martínez-Mayorga, MC Pitman, A Grossfield, SE Feller, MF Brown
Journal of the American Chemical Society 128 (51), 16502-16503, 2006
942006
Scaffold diversity analysis of compound data sets using an entropy‐based measure
JL Medina‐Franco, K Martínez‐Mayorga, A Bender, T Scior
QSAR & Combinatorial Science 28 (11‐12), 1551-1560, 2009
902009
Retinal dynamics underlie its switch from inverse agonist to agonist during rhodopsin activation
AV Struts, GFJ Salgado, K Martínez-Mayorga, MF Brown
Nature structural & molecular biology 18 (3), 392-394, 2011
882011
The impact of chemoinformatics on drug discovery in the pharmaceutical industry
K Martinez-Mayorga, A Madariaga-Mazon, JL Medina-Franco, ...
Expert Opinion on Drug Discovery 15 (3), 293-306, 2020
832020
Cruzain inhibitors: efforts made, current leads and a structural outlook of new hits
K Martinez-Mayorga, KG Byler, AI Ramirez-Hernandez, ...
Drug Discovery Today 20 (7), 890-898, 2015
822015
Database fingerprint (DFP): an approach to represent molecular databases
E Fernández-de Gortari, CR García-Jacas, K Martinez-Mayorga, ...
Journal of cheminformatics 9, 1-9, 2017
762017
Consensus models of activity landscapes with multiple chemical, conformer, and property representations
AB Yongye, K Byler, R Santos, K Martínez-Mayorga, GM Maggiora, ...
Journal of chemical information and modeling 51 (6), 1259-1270, 2011
702011
Pyridin‐2(1H)‐ones: A Promising Class of HIV‐1 Non‐nucleoside Reverse Transcriptase Inhibitors
JL Medina‐Franco, K Martínez‐Mayorga, C Juárez‐Gordiano, R Castillo
ChemMedChem: Chemistry Enabling Drug Discovery 2 (8), 1141-1147, 2007
632007
QuBiLS-MAS, open source multi-platform software for atom- and bond-based topological (2D) and chiral (2.5D) algebraic molecular descriptors computations
JR Valdés-Martiní, Y Marrero-Ponce, CR García-Jacas, ...
Journal of cheminformatics 9, 1-26, 2017
622017
Multitarget structure–activity relationships characterized by activity-difference maps and consensus similarity measure
JL Medina-Franco, AB Yongye, J Pérez-Villanueva, RA Houghten, ...
Journal of chemical information and modeling 51 (9), 2427-2439, 2011
552011
Balancing novelty with confined chemical space in modern drug discovery
JL Medina-Franco, K Martinez-Mayorga, N Meurice
Expert Opinion on Drug Discovery 9 (2), 151-165, 2014
542014
Synthesis, in vitro and computational studies of protein tyrosine phosphatase 1B inhibition of a small library of 2-arylsulfonylaminobenzothiazoles with antihyperglycemic activity
G Navarrete-Vazquez, P Paoli, I León-Rivera, R Villalobos-Molina, ...
Bioorganic & medicinal chemistry 17 (9), 3332-3341, 2009
542009
Retinal ligand mobility explains internal hydration and reconciles active rhodopsin structures
N Leioatts, B Mertz, K Martínez-Mayorga, TD Romo, MC Pitman, SE Feller, ...
Biochemistry 53 (2), 376-385, 2014
532014
The system can't perform the operation now. Try again later.
Articles 1–20